Hiro J - Search Results

1

The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.

Ojima E, Inoue Y, Watanabe H, Hiro J, Toiyama Y, Miki C, Kusunoki M. Ojima E, et al. Among authors: hiro j. Oncol Rep. 2006 Nov;16(5):1085-91. Oncol Rep. 2006. PMID: 17016597

2

Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapy.

Inoue Y, Shirane M, Miki C, Hiro J, Tanaka K, Kobayashi M, Mori K, Yanagi H, Kusunoki M. Inoue Y, et al. Among authors: hiro j. Int J Oncol. 2004 Dec;25(6):1641-9. Int J Oncol. 2004. PMID: 15547701 Clinical Trial.

3

Improved survival using multi-modality therapy in patients with lung metastases from colorectal cancer: a preliminary study.

Inoue Y, Miki C, Hiro J, Ojima E, Yamakado K, Takeda K, Kusunoki M. Inoue Y, et al. Among authors: hiro j. Oncol Rep. 2005 Dec;14(6):1571-6. Oncol Rep. 2005. PMID: 16273258 Clinical Trial.

4

in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.

Inoue Y, Tanaka K, Hiro J, Yoshiyama S, Toiyama Y, Eguchi T, Miki C, Kusunoki M. Inoue Y, et al. Among authors: hiro j. Int J Oncol. 2006 Feb;28(2):479-86. Int J Oncol. 2006. PMID: 16391804

5

Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer.

Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M. Miki C, et al. Among authors: hiro j. Clin Oncol (R Coll Radiol). 2006 Feb;18(1):60-6. doi: 10.1016/j.clon.2005.08.004. Clin Oncol (R Coll Radiol). 2006. PMID: 16477921

6

The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients.

Toiyama Y, Araki T, Yoshiyama S, Hiro J, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: hiro j. Surg Today. 2006;36(3):287-90. doi: 10.1007/s00595-005-3144-y. Surg Today. 2006. PMID: 16493544

7

The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines.

Toiyama Y, Inoue Y, Hiro J, Ojima E, Watanabe H, Narita Y, Hosono A, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: hiro j. Cancer Chemother Pharmacol. 2007 May;59(6):733-42. doi: 10.1007/s00280-006-0327-1. Epub 2006 Sep 7. Cancer Chemother Pharmacol. 2007. PMID: 16957932

8

Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study.

Miki C, Inoue Y, Hiro J, Ojima E, Araki T, Uchida K, Kusunoki M. Miki C, et al. Among authors: hiro j. Dis Colon Rectum. 2006 Nov;49(11):1710-8. doi: 10.1007/s10350-006-0697-9. Dis Colon Rectum. 2006. PMID: 16990975

9

The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia.

Uchida K, Inoue M, Otake K, Yoshiyama S, Toiyama Y, Hiro J, Araki T, Miki C, Kusunoki M. Uchida K, et al. Among authors: hiro j. J Pediatr Surg. 2006 Oct;41(10):1657-62. doi: 10.1016/j.jpedsurg.2006.05.058. J Pediatr Surg. 2006. PMID: 17011264

10

Irinotecan cytotoxicity does not necessarily depend on the UGT1A1 polymorphism but on fluoropyrimidine: a molecular case report.

Inoue Y, Miki C, Watanabe H, Hiro J, Toiyama Y, Ojima E, Nakatani K, Nobori T, Kusunoki M. Inoue Y, et al. Among authors: hiro j. Oncol Rep. 2006 Nov;16(5):971-4. Oncol Rep. 2006. PMID: 17016579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters